Real-world outcomes of low-dose atropine therapy on myopia progression during the COVID-19 pandemic

Eiman Usmani, Stephanie Callisto,Weng Onn Chan,Deepa Taranath

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY（2023）

引用 0|浏览3

暂无评分

摘要

Low-dose atropine was shown to be beneficial in a real-world clinical setting, despite interruptions to follow-ups secondary to COVID-19 pandemic. A 0.05% dose of atropine may be effective in cases where 0.01% was ineffective.

查看译文

关键词

myopia progression,pandemic,australian cohort

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要